Amidas

<p>3-Bromopropionamide is an antibacterial agent that inhibits bacterial growth by blocking the synthesis of proteins. It is a synthetic amide with significant antibacterial activity against S. aureus. 3-Bromopropionamide has been shown to be effective against drug-resistant bacteria, including those that are resistant to metalloid salts or alkylene compounds. This substance also has psychomimetic effects and may be useful for studying the kinetics of protein synthesis in cells. 3-Bromopropionamide can be used as a linker to attach other molecules to proteins, which could allow them to penetrate cell membranes more easily.</p>

<p>L-Tryptophanamide hydrochloride is a fluorescent compound that belongs to the amides. It has been shown to have invertase activity and be hydrated in both isooctane and water. L-Tryptophanamide hydrochloride also has an anxiolytic effect on mice, which may be due to its ability to inhibit the production of serotonin at synapses by blocking the enzyme tryptophan hydroxylase. The drug is used for the treatment of anxiety disorders, including generalized anxiety disorder (GAD) and posttraumatic stress disorder (PTSD). This drug has a molecular profile that can be detected by fluorescence spectrometry, with an enhancement factor of 1.5-2.5.</p>

<p>Pyridine-3-sulfonamide is a diazonium salt that has shown anticancer activity against human colon HCT116 cells. It inhibits the proliferation of leukemia cells by inhibiting the uptake of glucose, and it also has inhibitory properties on l1210 murine leukemia cells. Pyridine-3-sulfonamide binds to metal surfaces and accumulates in the cytoplasm of cancer cells, which may be due to its structural formula consisting of a pyridine group and a sulfonamide group. This compound can be used as an anticancer drug for cancer treatment.</p>

4-Amino-N,N-dipropylbenzenesulfonamide is a molecule that has been shown to be an effective antimicrobial agent against bacteria. It inhibits the growth of bacteria by inhibiting the enzyme that catalyzes the formation of acyl radicals from alkoxy radicals and ethoxycarbonyl groups. This prevents bacterial cell membrane lipid peroxidation and thus prevents bacterial growth. 4-Amino-N,N-dipropylbenzenesulfonamide also inhibits bacterial DNA synthesis by interfering with the enzymes that synthesize nucleotides and proteins. The molecule has been shown to bind to nucleophilic sites on DNA gyrase, preventing its activity, which leads to inhibition of DNA replication. 4-Amino-N,N-dipropylbenzenesulfonamide can also bind to pyrazolyl groups on carbanion molecules and form a stable carbamate group.

<p>Please enquire for more information about N-tert-Butoxycarbonyl-L-isoleucineamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Adrafinil is a prodrug. It is primarily metabolized in vivo to modafinil, resulting in very similar pharmacological effects.</p>

<p>2-Oxo-3-hydroxy-N-methyl-N-propyl D-lysergamide (2OMD) is a metabolite of the drug lysergic acid diethylamide (LSD). It can be detected in urine, blood, and saliva. The detection time in urine is approximately 3 hours after ingestion. 2OMD can be found by chromatography techniques, such as thin layer chromatography or high performance liquid chromatography. It can also be detected using mass spectrometric techniques, such as gas chromatography/mass spectrometry or liquid chromatography/mass spectrometry. 2OMD can also be detected in urine samples by calibrations with standards of known concentration and by the use of analytical methods such as gas chromatography/mass spectroscopy.</p>

N-Methyl picolinamide is a novel anticancer agent that inhibits the activity of BCR-ABL kinase. It has been shown to be effective against human colon cancer cells (HCT116) and breast cancer cells (MCF-7). N-Methyl picolinamide binds to the ATP binding site of BCR-ABL kinase, inhibiting its enzymatic activity. The compound also binds to annexin II and blocks cell cycle progression at G2/M phase. The chemical structure of N-Methyl picolinamide includes an amide group, which may lead to low bioavailability. This drug has significant inhibitory activities against nitrogen atoms and inhibition constants for both the A and B forms of the enzyme.

Please enquire for more information about N-(5-bromo-pyridin-2-yl)-2,2-dimethyl-propionamide including the price, delivery time and more detailed product information at the technical inquiry form on this page

<p>Please enquire for more information about Boc-L-proline N,O-dimethylhydroxamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

Fluoxetine is a potent inhibitor of the enzyme cytochrome P450 (CYP) 2C19. The inhibition of CYP2C19 by fluoxetine may lead to an increase in the plasma concentration of other drugs that are metabolized by this enzyme, such as glipizide and hydroxycyclohexyl. Fluoxetine inhibits human uric acid secretion and increases plasma concentrations of uric acid. This drug also inhibits human erythrocyte dihydropyrimidine dehydrogenase, leading to increased blood levels of pyrimidines, especially cytotoxic ones like 6-fluoro-3-indoxyl-beta-D-galactopyranoside. Fluoxetine has been shown to have a protective effect against acetaminophen toxicity in rats because it enhances the conversion of acetaminophen to its less toxic metabolite N-acetylcysteine.

Please enquire for more information about 2-Cyano-N-cyclohexyl-N-methylacetamide including the price, delivery time and more detailed product information at the technical inquiry form on this page

<p>Please enquire for more information about (NZ)-4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]piperidin-2-ylidene]benzenesulfonamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

Please enquire for more information about N-(1,2,3,4-Tetrahydro-7-methoxy-1-oxo-2-naphthalenyl)propanamide including the price, delivery time and more detailed product information at the technical inquiry form on this page

2-Ethyl-2-phenylmalonamide (2-EPMA) is a metabolite of primidone that acts as an inhibitor of glutamate dehydrogenase and may be used in the treatment of epilepsy. It has been shown to be effective in treating seizures caused by carbamazepine, phenobarbital, or phenytoin. 2-EPMA is also used to measure enzyme activities in serum, which can be used as a diagnostic tool for liver diseases. 2-EPMA is typically prepared for use as an enzyme inhibitor by diluting it with high salt or human serum. This compound may have carcinogenic potential and should not be administered with single doses greater than 100 mg/kg body weight. 2-EPMA interacts with many other drugs such as phenobarbital, phenytoin, and carbamazepine.

<p>Please enquire for more information about N-(3-Bromo-4-hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

Please enquire for more information about N-Methyl-2-[[3-[(1e)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide including the price, delivery time and more detailed product information at the technical inquiry form on this page

5-(2-Aminopropyl)-2-methoxybenzenesulphonamide is a trimethyl derivative of the aminopropyl group. It is used as a reagent to introduce hydroxymethyl groups into organic compounds. 5-(2-Aminopropyl)-2-methoxybenzenesulphonamide reacts with hydrochloric acid and an organic solvent in the preparation process. In the Friedel-Crafts reaction, 5-(2-Aminopropyl)-2-methoxybenzenesulphonamide reacts with d-alanine to form an optical isomer, which can be converted to its racemic form by ammonolysis. This compound is also used as a prostatic agent and an amide in the synthesis of benzene and phenoxymethyl alcohols.

<p>Lacosamide is an antiepileptic drug that has been shown to be bioequivalent to the reference product, Gabapentin. Lacosamide binds to voltage-gated sodium channels and is thought to have a similar clinical profile as Gabapentin. It is used in the treatment of partial seizures (with or without secondary generalization) and adjunctive therapy for generalized seizures in adults and children aged 2 years or older. Lacosamide can interact with other drugs, such as gabapentin, by increasing their serum concentrations. This interaction may lead to adverse effects such as dizziness and confusion. Lacosamide plasma concentrations are measured using LC-MS/MS methods after a two-way crossover study in healthy human volunteers. This study also showed that lacosamide is excreted unchanged in urine samples at a rate of about 50% over 24 hours, indicating that it does not undergo extensive metabolism in humans.</p>

N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide is an anticancer drug that belongs to the class of phenethyl derivatives. It is a radiosensitizer that inhibits DNA and RNA synthesis, leading to cancer cell death. The drug has been shown to have a chiral center and two enantiomers, with the (S)-enantiomer being more active than the (R)-enantiomer. N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide has been shown to be effective in animal models for brain tumors and breast cancer cells. It has also been shown to be effective against leukemia cells, which are resistant to other treatments. N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4